First NEUROLITH in Ukraine: BRAINSPOT LVIV now treats Alzheimer's patients with TPS

Transcranial Pulse Stimulation (TPS®) celebrates its debut in Ukraine: The first NEUROLITH® system was installed in the western Ukrainian city and cultural centre of Lviv (approx. 750,000 inhabitants) on 12 January 2022. Now, Alzheimer's patients can receive treatment at »BRAINSPOT LVIV«, a clinic for neuromodulation (Director: Tomas Dzeminskyy, Chief Medical Officer: Andrii Hul). The first therapy sessions have already taken place.

Continue reading
0
  661 Hits

Transcranial Pulse Stimulation (TPS): new study demonstrates sham-controlled long-term effects for the first time

A study by Matt et al. (Medical University of Vienna, University Department of Neurology) published in January 2022 investigates the long-term effects of Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system on human brain and behaviour.1 The randomised, sham-controlled and double-blinded study provides sham-controlled evidence for such effects for the first time.

Continue reading
0
  855 Hits

Transcranial Pulse Stimulation (TPS) improves depressive symptoms of Alzheimer’s patients

Another study by Matt et al. (Medical University of Vienna, University Department of Neurology) published in February 2022 now presented a detailed sub-analysis of possible anti-depressive effects of Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system based on neuropsychological and functional imaging data.2

Continue reading
2
  359 Hits

STORZ MEDICAL Live Webinar »Transcranial Pulse Stimulation (TPS) in Alzheimer’s Dementia: Practical issues and treatment examples« on Wednesday, 15 September 2021, 18:00 – 18:45 (CET)

In this information-packed webinar, neurologist Dr Lars Wojtecki talks about scientific background and clinical data of Transcranial Pulse Stimulation (TPS®) in patients with Alzheimer’s Dementia as well as practical experience with handling and clinical effects.

Continue reading
0
  880 Hits

Germany, Austria, Turkey: Three more neurological specialist clinics add TPS to their range of therapies

Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system for the treatment of Alzheimer's patients is increasingly gaining momentum: In early June 2021, three more devices were installed in renowned neurological specialist clinics in Germany, Austria and Turkey.

Continue reading
0
  898 Hits

STORZ MEDICAL’s NEUROLITH® receives CE approval – Transcranial Pulse Stimulation (TPS) on the central nervous system of patients with Alzheimer’s disease

Neurolith_CE_Approval

In December 2018, STORZ MEDICAL has received the CE approval for the NEUROLITH®, a new therapy system for the treatment of neurological diseases.

Continue reading
26
  16890 Hits

Alzheimer’s treatment: study on STORZ MEDICAL’s Transcranial Pulse Stimulation (TPS) is among the top 10% most downloaded papers in Advanced Science

In December 2019, the first study1 on Transcranial Pulse Stimulation (TPS®) with STORZ MEDICAL’s NEUROLITH® system was published in the prestigious journal Advanced Science. In the study, Beisteiner et al. evaluate the TPS® method and present treatment results. The presented data shows that it is possible to improve brain performance with TPS® and that there is a long-term effect.

Continue reading
0
  4080 Hits
Linkedin Channel Facebook Channel Instagram Channel Twitter Youtube Channel